BSE Live
Nov 07, 16:01Prev. Close
377.30
Open Price
378.80
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 07, 15:49Prev. Close
377.00
Open Price
380.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
379.50 (314)
| Profit & Loss account of Kilitch Drugs (India) (in Rs. Cr.) | Mar 05 | Mar 04 | |
| 12 mths | 12 mths | ||
| INCOME | |||
| Revenue From Operations [Gross] | 23.81 | 17.97 | |
| Less: Excise/Sevice Tax/Other Levies | 1.60 | 0.71 | |
| Revenue From Operations [Net] | 22.21 | 17.26 | |
| Total Operating Revenues | 22.21 | 17.26 | |
| Other Income | 2.84 | 0.27 | |
| Total Revenue | 25.05 | 17.53 | |
| EXPENSES | |||
| Cost Of Materials Consumed | 19.94 | 12.84 | |
| Purchase Of Stock-In Trade | 0.00 | 0.00 | |
| Operating And Direct Expenses | 1.19 | 1.30 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -0.08 | 0.16 | |
| Employee Benefit Expenses | 0.59 | 0.57 | |
| Finance Costs | 0.00 | 0.00 | |
| Depreciation And Amortisation Expenses | 0.55 | 0.55 | |
| Other Expenses | 2.24 | 1.71 | |
| Total Expenses | 24.53 | 17.24 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 0.52 | 0.29 | |
| Exceptional Items | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 0.52 | 0.29 | |
| Tax Expenses-Continued Operations | |||
| Current Tax | 0.10 | 0.13 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | |
| Deferred Tax | 0.01 | 0.00 | |
| Tax For Earlier Years | 0.00 | 0.00 | |
| Total Tax Expenses | 0.11 | 0.13 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 0.41 | 0.17 | |
| Profit/Loss From Continuing Operations | 0.41 | 0.27 | |
| Profit/Loss For The Period | 0.41 | 0.27 | |
| OTHER ADDITIONAL INFORMATION | |||
| EARNINGS PER SHARE | |||
| Basic EPS (Rs.) | 0.64 | 0.45 | |
| Diluted EPS (Rs.) | 0.64 | 0.45 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | |||
| Imported Raw Materials | 0.00 | 0.00 | |
| Indigenous Raw Materials | 17.04 | 12.02 | |
| STORES, SPARES AND LOOSE TOOLS | |||
| Imported Stores And Spares | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | |||
| Equity Share Dividend | 0.00 | 0.00 | |
| Tax On Dividend | 0.00 | 0.00 | |
| Equity Dividend Rate (%) | 0.00 | 0.00 |
20.05.2025
Kilitch Drugs Consolidated March 2025 Net Sales at Rs 61.23 crore, up 36.61% Y-o-Y
20.05.2025
Kilitch Drugs Standalone March 2025 Net Sales at Rs 56.30 crore, up 43.87% Y-o-Y
28.02.2025
Kilitch Drugs Consolidated December 2024 Net Sales at Rs 56.17 crore, up 76.65% Y-o-Y
17.02.2025
Kilitch Drugs Standalone December 2024 Net Sales at Rs 46.51 crore, up 56.27% Y-o-Y